tiprankstipranks
Diamedica Therapeutics (DMAC)
NASDAQ:DMAC
US Market
DMAC
Diamedica Therapeutics
RESEARCH TOOLSreports

Diamedica Therapeutics (DMAC) Cash flow

569 Followers

Diamedica Therapeutics Cash Flow

DMAC's free cash flow for Q4 2025 was $-7.77M. For the 2025 fiscal year, DMAC's free cash flow was decreased by $-7.00M and operating cash flow was $-7.76M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -29.06M$ -22.08M$ -18.73M$ -11.51M$ -12.25M
Investing Cash Flow
$ -2.19M$ 8.56M$ -18.30M$ 11.54M$ -20.54M
Financing Cash Flow
$ 43.88M$ 11.99M$ 36.84M$ -6.00K$ 30.09M
End Cash Position
$ 15.65M$ 3.02M$ 4.54M$ 4.73M$ 4.71M
Free Cash Flow
$ -29.10M$ -22.10M$ -18.75M$ -11.59M$ -12.27M
Currency in USD

Diamedica Therapeutics Cash Flow